Alnylam Pharmaceuticals (ALNY) earnings per share (EPS)

Earnings per share · fiscal 2025
$2.33

Alnylam Pharmaceuticals (ALNY) reported diluted earnings per share of $2.33 in fiscal 2025 (the year ended December 31, 2025). In fiscal 2024 the figure was -$2.18. Figures as of 17 Nov 2026, 23:41 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Earnings per share, fiscal 2025
$2.33
Highest on record
$2.33fiscal 2025
Lowest on record
-$9.30fiscal 2022
Fiscal years on record
72019–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Alnylam Pharmaceuticals earnings per share (EPS), in more detail

Across the 7 fiscal years on record (2019–2025), the highest was $2.33 in fiscal 2025 and the lowest -$9.30 in fiscal 2022.

History · 7 fiscal years

Earnings per share by fiscal year

Alnylam Pharmaceuticals earnings per share (EPS), year by year

Alnylam Pharmaceuticals (ALNY) earnings per share (EPS) by fiscal year
Fiscal yearEarnings per shareChangeYear ended
2025$2.33—
2024-$2.18—
2023-$3.52—
2022-$9.30—
2021-$7.20—
2020-$7.46—
2019-$8.11—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Earnings per share is net income divided by the diluted number of shares, as the company reports it; older years are re-based for later stock splits.

How to read it

It shows how much profit stands behind each share, so it rises when profit grows or when buybacks shrink the share count.

Earnings per share at health care companies of similar size

Earnings per share of Alnylam Pharmaceuticals and comparable companies
CompanyEarnings per shareFiscal year
Tenet Healthcare THC$15.492025
BioNTech BNTX-€4.702025
Guardant Health GH-$3.322025
Alnylam Pharmaceuticals ALNY$2.332025
Zimmer Biomet Holdings ZBH$3.552025
Medpace Holdings MEDP$15.282025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on ALNY

Alnylam Pharmaceuticals, figure by figure

Alnylam Pharmaceuticals (ALNY) overview: price, valuation and scorecardAll health care companies by market value

Alnylam Pharmaceuticals earnings per share (EPS): questions and answers

What is Alnylam Pharmaceuticals's diluted earnings per share?

Alnylam Pharmaceuticals (ALNY) reported diluted earnings per share of $2.33 in fiscal 2025 (the year ended December 31, 2025). In fiscal 2024 the figure was -$2.18.

What are the highest and lowest diluted earnings per share figures on record for Alnylam Pharmaceuticals?

Across the 7 fiscal years on record (2019–2025), the highest was $2.33 in fiscal 2025 and the lowest -$9.30 in fiscal 2022.

How is Alnylam Pharmaceuticals's diluted earnings per share calculated?

Earnings per share is net income divided by the diluted number of shares, as the company reports it; older years are re-based for later stock splits.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Alnylam Pharmaceuticals (ALNY) earnings per share (EPS)”, data as of 17 November 2026. https://funkfolio.com/stock/ALNY/eps

Underlying data: the company's filings with the SEC and Yahoo Finance.